srxhealth.com - Utang jangka cendhak marang modal SRXH

SRXH (SRx Health Solutions Inc) - tandha merek perusahaan

The market capitalization trend of SRx Health Solutions Inc. (SRXH) reflects the dynamics of a company expanding drug distribution through IT automation to bypass the constraints of physical laboratories. The current figure stands at 0.00. The business relies on a personalized service approach, which allows it to maintain high margins and avoid price competition. However, military conflicts and sanctions create risks for global supplies, reducing available target markets.

SRXH - Rasio utang jangka cendhak marang ekuitas SRx Health Solutions Inc. ing rentang 01.05.2025 - 31.10.2026
Produk merek SRx Health Solutions Inc.

An investment audit of SRx Health Solutions Inc. (SRXH) requires an assessment of liability structure stability via the ratio of short-term borrowings to total capital, which determines the company's dependence on the cost of liquidity. For a B2B operator of complex prescription programs, the trend of short-term liabilities relative to equity reflects the balance between expansion into the rare disease niche and refinancing risks amid shifting interest rates.

Pesaing utama

Utang jangka cendhak marang ekuitas Vertex Pharmaceuticals Inc. (VRTX)|ALNY: Kewajiban jangka cendhak marang ekuitas|Utang jangka cendhak marang modal INSM (Insmed Incorporated)|unither.com (UTHR) - Kewajiban jangka cendhak marang modal|BioMarin - Utang jangka cendhak marang modal|BridgeBio Pharma (BBIO) - Rasio utang jangka cendhak marang ekuitas|BGM: Utang jangka cendhak marang modal|COGT - Koefisien utang jangka cendhak marang modal|XERS (Xeris Biopharma) - Utang jangka cendhak marang modal|Utang jangka cendhak marang modal kerostx.com|Utang jangka cendhak marang ekuitas Arcturus Therapeutics Holdings Inc. (ARCT)|Utang jangka cendhak marang ekuitas ETON (Eton Pharmaceuticals Inc)|Utang jangka cendhak marang modal KMDA (Kamada Corp)|Koefisien utang jangka cendhak marang modal Fulcrum Corp (FULC)|ABEO: Rasio utang jangka cendhak marang ekuitas|Kewajiban jangka cendhak marang ekuitas MREO|PLX: Utang jangka cendhak marang modal|Kewajiban jangka cendhak marang modal Pliant Therapeutics, Inc. (PLRX)|APLT (Applied Therapeutics) - Utang jangka cendhak marang modal|Rasio utang jangka cendhak marang modal RNTX (Aileron Therapeutics)|Rasio utang jangka cendhak marang ekuitas GELS (Gelteq Limited)|AYTU (aytubio.com) - Rasio tanggungan utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas Chemomab Therapeutics Ltd. CMMB|PLRZ (Polyrizon Limited) - Kewajiban jangka cendhak marang ekuitas|Zentaris - Utang jangka cendhak marang modal|Rasio tanggungan utang jangka cendhak marang modal CYTH (Cyclo Therapeutics, Inc)|INZY: Utang jangka cendhak marang modal|reneopharma.com (RPHM) - Utang jangka cendhak marang modal|Utang jangka cendhak marang ekuitas COSCIENS Biopharma